Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children

PHASE3CompletedINTERVENTIONAL

Enrollment

1,920

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

November 30, 2002

Conditions

Healthy

Interventions

BIOLOGICAL

CAIV-T, Liquid

Trial Locations (2)

Queen Sirikit National Institute of Child Health (Children's Hospital), Bangkok

Department of Microbiology, Research Institute for Tropical Medicine, City of Muntinlupa